We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Presents Comprehensive Range of One-Stop IVD Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025
Print article
Image: Fapon is sharing the latest industry insights with global IVD professionals at Medlab Middle East 2025 (Photo courtesy of Fapon Biotech)
Image: Fapon is sharing the latest industry insights with global IVD professionals at Medlab Middle East 2025 (Photo courtesy of Fapon Biotech)

Fapon Biotech (Dongguan, China) is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with its global partners at Medlab Middle East 2025. Leveraging its cutting-edge technologies and vast industry experience, Fapon has introduced its technology transfer and local manufacturing services to best underscore its commitment to enhancing local IVD industry development.

At the exhibition, Fapon is presenting a range of IVD solutions covering a wide spectrum of technology applications, including chemiluminescence immunoassay (CLIA), biochemistry, next-generation sequencing (NGS), polymerase chain reaction (PCR), lateral flow assay (LFA), and fluorescence immunoassay (FIA) for both clinical diagnostic laboratories and point-of-care testing (POCT) scenarios. Leveraging its strong foundation in IVD technologies, Fapon integrates open-system instruments, reagent services, and raw materials into One-stop IVD solutions. This approach ensures reliable, versatile, and seamless services for its IVD partners, especially local IVD companies and distributors that are establishing or expanding their own IVD production lines. Ultimately, these efforts benefit local hospitals and patients. Fapon's goal is to elevate the product portfolios of global IVD manufacturers and reduce their time-to-market through technology transfer and local manufacturing.

Fapon's CLIA and biochemistry product lines exemplify its expertise in One-stop IVD solutions. Its CLIA One-stop solution includes the Shine i-series open-system CLIA analyzers for low- to ultra-high-throughput testing, alongside over 80 reagent services for assays such as vitamin D, NT-proBNP, hs-cTnI, and PCT, and core IVD raw materials. Fapon is able to provide one-stop CLIA products and services from development, evaluation/registration, and QMS construction to after-sales. In addition, Fapon's biochemistry One-stop solution offers matching antibodies, antigens, latex particles, coupling procedures, and biochemistry analyzers, enabling its partners to successfully develop their IVD tests in a short time. Collectively, they demonstrate Fapon's commitment to advancing diagnostic technologies and customization services to meet the localization needs of the IVD manufacturers. Fapon's PCR one-stop solution can provide POCT instruments that can provide results in as fast as 30 minutes, along with customized reagent services. Fapon's FIA one-stop solution can offer multiple analyzers and reagents for over 40 types of diseases.

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Centromere B Assay
Centromere B Test

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.